acrolein has been researched along with fluorouracil in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, R; Farquhar, D; Khan, S | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Liu, SL; Qi, MH; Yu, C; Zou, X | 1 |
| Cheng, X; Fang, Q; Tang, R; Wang, X; Xu, X; Xue, Y; Yang, L | 1 |
4 other study(ies) available for acrolein and fluorouracil
| Article | Year |
|---|---|
5'-[4-(Pivaloyloxy)-1,3,2-dioxaphosphorinan-2-yl]-2'-deoxy-5-fluorouridine: a membrane-permeating prodrug of 5-fluoro-2'-deoxyuridylic acid (FdUMP).
Topics: Animals; Antimetabolites, Antineoplastic; Cell Division; Cell Membrane; CHO Cells; Cricetinae; Esterases; Fluorodeoxyuridylate; Leukemia P388; Male; Mice; Phosphoric Monoester Hydrolases; Prodrugs; Swine | 1995 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cinnamaldehyde/chemotherapeutic agents interaction and drug-metabolizing genes in colorectal cancer.
Topics: Acrolein; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Cinnamomum aromaticum; Colorectal Neoplasms; DNA Topoisomerases, Type I; DNA-Binding Proteins; Drug Synergism; Endonucleases; Fluorouracil; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Inactivation, Metabolic; Organoplatinum Compounds; Orotate Phosphoribosyltransferase; Oxaliplatin; Thymidylate Synthase | 2014 |
Self-assembled 5-fluorouracil-cinnamaldehyde nanodrugs for greatly improved chemotherapy in vivo.
Topics: Acrolein; Animals; Antimutagenic Agents; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Drug Carriers; Drug Liberation; Drug Synergism; Flavoring Agents; Fluorouracil; Hep G2 Cells; Humans; Male; Mice; Mice, Inbred ICR; Nanoparticles | 2021 |